Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease

被引：1271

作者：

Katz, Philip O. ^{[1
]}

Gerson, Lauren B. ^{[2
]}

Vela, Marcelo F. ^{[3
,4
]}

机构：

[1] Einstein Med Ctr, Div Gastroenterol, Philadelphia, PA USA

[2] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA

[3] Baylor Coll Med, Div Gastroenterol, Houston, TX 77030 USA

[4] Michael E DeBakey VA Med Ctr, Houston, TX USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷 / 03期

关键词：

PROTON-PUMP INHIBITORS; MULTICHANNEL INTRALUMINAL IMPEDANCE; TRANSORAL INCISIONLESS FUNDOPLICATION; HELICOBACTER-PYLORI INFECTION; COMMUNITY-ACQUIRED PNEUMONIA; DELAYED-RELEASE FORMULATION; ACID SUPPRESSIVE THERAPY; SHORT-TERM TREATMENT; OMEPRAZOLE; 40; MG; BODY-MASS INDEX;

D O I：

10.1038/ajg.2012.444

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：308 / 328

页数：21

共 184 条

[1]

Evaluation of patients with suspected laryngopharyngeal reflux: A practical approach [J].

Abou-Ismail A. ;

Vaezi M.F. .

Current Gastroenterology Reports, 2011, 13 (3) :213-218

[2]

Intralesional steroid injection in benign esophageal strictures resistant to bougie dilation [J].

Altintas, E ;

Kacar, S ;

Tunc, B ;

Sezgin, O ;

Parlak, E ;

Altiparmak, E ;

Saritas, U ;

Sahin, B .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (12) :1388-1391

[3]

Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity [J].

Appelmelk, BJ ;

SimoonsSmit, I ;

Negrini, R ;

Moran, AP ;

Aspinall, GO ;

Forte, JG ;

DeVries, T ;

Quan, H ;

Verboom, T ;

Maaskant, JJ ;

Ghiara, P ;

Kuipers, EJ ;

Bloemena, E ;

Tadema, TM ;

Townsend, RR ;

Tyagarajan, K ;

Crothers, JM ;

Monteiro, MA ;

Savio, A ;

DeGraaff, J .

INFECTION AND IMMUNITY, 1996, 64 (06) :2031-2040

[4]

Atkins D, 2004, BMJ-BRIT MED J, V328, P1490

[5]

Systems for grading the quality of evidence and the strength of recommendations II:: Pilot study of a new system -: art. no. 25 [J].

Atkins, D ;

Briss, PA ;

Eccles, M ;

Flottorp, S ;

Guyatt, GH ;

Harbour, RT ;

Hill, S ;

Jaeschke, R ;

Liberati, A ;

Magrini, N ;

Mason, J ;

O'Connell, D ;

Oxman, AD ;

Phillips, B ;

Schünemann, H ;

Edejer, TTT ;

Vist, GE ;

Williams, JW .

BMC HEALTH SERVICES RESEARCH, 2005, 5 (1)

[6]

Patterns of proton pump inhibitor use in clinical practice [J].

Barrison, AF ;

Jarboe, LA ;

Weinberg, BM ;

Nimmagadda, K ;

Sullivan, LM ;

Wolfe, MM .

AMERICAN JOURNAL OF MEDICINE, 2001, 111 (06) :469-473

[7]

Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection [J].

Bavishi, C. ;

DuPont, H. L. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (11-12) :1269-1281

[8]

Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease [J].

Becher, A. ;

El-Serag, H. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (06) :618-627

[9]

Systematic review: ageing and gastro-oesophageal reflux disease symptoms, oesophageal function and reflux oesophagitis [J].

Becher, A. ;

Dent, J. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (04) :442-454

[10]

Clopidogrel with or without Omeprazole in Coronary Artery Disease. [J].

Bhatt, Deepak L. ;

Cryer, Byron L. ;

Contant, Charles F. ;

Cohen, Marc ;

Lanas, Angel ;

Schnitzer, Thomas J. ;

Shook, Thomas L. ;

Lapuerta, Pablo ;

Goldsmith, Mark A. ;

Laine, Loren ;

Scirica, Benjamin M. ;

Murphy, Sabina A. ;

Cannon, Christopher P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20) :1909-1917

← 1 2 3 4 5 6 7 8 9 10 →